Responses
Late-breaking abstracts
Clinical trials in-progress
801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
